drugset / Trial / NCT03537612

Sensorial and Physiological Mechanism-based Assessments of Perioperative Pain

NCT03537612

Phase 3 Terminated 15 enrolled Dr. Jean A. Ouellet, MD, FRCSC
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The overall goal of this proposal is to determine if quantitative sensory testing (QST) assessing pain modulation can be used as a clinical tool to optimize perioperative pain management. The central hypothesis is that the identification of patient's sensory pain profile allows personalizing therapeutic approaches to improve individualized pain management and thus prevents pain chronicity.

Timeline

Start
2018-06-22
Primary completion
2022-04-05
Completion
2022-04-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Clonidine Other / unclassified 100 ug Intrathecal
Subject Morphine Other / unclassified 5 ug/kg Intrathecal

Indications